孙进 - 沈阳药科大学 - 无涯创新学院

个人简介

教育经历 1996.9 – 2002.6 博士，沈阳药科大学药剂学，博士期间在日本北海道药科大学留学一年半 1992.9 – 1996.6 学士，安徽中医药大学工作经历 2002– 至今沈阳药科大学教授，沈阳药科大学无涯创新学院荣誉奖励 1.教育部“长江学者特聘教授” 2.国家“万人计划”科技创新领军人才 3.科技部“中青年科技领军人才” 4.教育部“新世纪优秀人才支持计划” 5.辽宁省特聘教授 6.辽宁省优秀专家 7.辽宁省“药用辅料与包材工程技术研究中心”主任

研究领域

1、纳米药物的研究 2、生物药剂学的研究 3、制剂新技术和新剂型

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Zhao D, Tao W, Li S, Chen Y, Sun Y, He Z, Sun B, Sun J*. Apoptotic body-mediated intercellular delivery for enhanced drug penetration and whole tumor destruction.ScienceAdvances,2021;7(16):eabg0880.(IF=12) Yang, Y; Sun, B; Zuo, S; Li, X; Zhou, S; Li, L; Luo, C; Liu, H; Cheng, M; Wang, Y; Wang, S; He, Z; Sun, J*. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity.ScienceAdvances,2020;6(45):eabc1725. (IF=12) Sun B, Luo C, Zhang X, Guo M, Sun M, Yu H, Chen Q, Yang W, Wang M, Zuo S, Chen P, Kan Q, Zhang H, Wang Y, He Z, Sun J*. Probing the impact of sulfur/selenium/carbon linkageson prodrug nanoassemblies for cancer therapy. Nature Communication, 2019;10(1):3211. (IF=11.8) Zhang W, Song S, Wang H, Wang Q, Li D, Zheng S, Xu Z, Zhang H, Wang J, Sun J*. In vivo irreversible albumin-binding near-infrared dye conjugate as a naked-eye and fluorescence dual-mode imaging agent for lymph node tumor metastasis diagnosis. Biomaterials. 2019;217:119279. (IF=10.3) Wang M, Zhai Y*, Ye H, Lv Q, Sun B, Luo C, Jiang Q, Zhang H, Xu Y, Jing Y, Huang L, Sun J*, He Z*. High Co-loading Capacity and Stimuli-Responsive Release Based on Cascade Reaction of Self-Destructive Polymer for Improved Chemo-Photodynamic Therapy. ACSNano. 2019;13(6):7010-7023.(IF=13.9) Ye H, Wang K, Wang M, Liu R, Song H, Li N, Lu Q, Zhang W, Du Y, Yang W, Zhong L, Wang Y, Yu B, Wang H, Kan Q, Zhang H, Wang Y, He Z*, Sun J*. Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition. Biomaterials.2019; 206:1-12.(IF=10.3) Sun B, Luo C, Yu H, Zhang X, Chen Q, Yang W, Wang M, Kan Q, Zhang H, Wang Y, He Z*, Sun J*. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. Nano Lett. 2018;18(6):3643-3650(IF=12.3) Luo C, Sun J*, Liu D, Sun B, Miao L, Musetti S, Li J, Han X, Du Y, Li L, Huang L, He Z*.Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy,Nano Letter,2016;16(9):5401-8. (IF=13.78) Luo C, Sun J*, Sun B, He Z*.Prodrug-based nanoparticulate drug delivery strategies for cancer therapy,Trends Pharmacol Sci, 2014; 35(11):556-566. (IF=11.84) Wang G, Chen H, Zhao D, Ding D, Sun M, Kou L, Luo C, Zhang D, Yi X, Dong J, Wang J, Liu X, He Z, Sun J*,Combination of l-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral Prodrugs,J Med Chem , DOI:10.1021/acs.jmedchem.7b00049.(IF=5.59)